Cargando…

The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications

Telomere maintenance mechanisms (i.e., telomerase activity (TA) and the alternative lengthening of telomere (ALT) mechanism) contribute to tumorigenesis by providing unlimited proliferative capacity to cancer cells. Although the role of either telomere maintenance mechanisms seems to be equivalent i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Recagni, Marta, Bidzinska, Joanna, Zaffaroni, Nadia, Folini, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226354/ https://www.ncbi.nlm.nih.gov/pubmed/32290440 http://dx.doi.org/10.3390/cancers12040949

Ejemplares similares

On the Road to Fight Cancer: The Potential of G-Quadruplex Ligands as Novel Therapeutic Agents
por: Alessandrini, Irene, et al.
Publicado: (2021)

G-Quadruplex Structures in the Human Genome as Novel Therapeutic Targets
por: Bidzinska, Joanna, et al.
Publicado: (2013)

Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks
por: Zhang, Jia-Min, et al.
Publicado: (2020)

The Molecular Mechanisms and Therapeutic Prospects of Alternative Lengthening of Telomeres (ALT)
por: Sohn, Eric J., et al.
Publicado: (2023)

Alternative Lengthening of Telomeres in Pediatric High-Grade Glioma and Therapeutic Implications
por: Umaru, Banlanjo, et al.
Publicado: (2023)

miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an “ALT-like” phenotype in diffuse malignant peritoneal mesothelioma cells
por: Cimino-Reale, Graziella, et al.
Publicado: (2017)

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies
por: Kent, Thomas, et al.
Publicado: (2020)

Alternative lengthening of telomeres: remodeling the telomere architecture
por: Conomos, Dimitri, et al.
Publicado: (2013)

Alternative Lengthening of Telomeres and Mediated Telomere Synthesis
por: Hou, Kailong, et al.
Publicado: (2022)

The alternative lengthening of telomeres mechanism jeopardizes telomere integrity if not properly restricted
por: Silva, Bruno, et al.
Publicado: (2022)

Detection of alternative lengthening of telomeres mechanism on tumor sections
por: Claude, Eloïse, et al.
Publicado: (2021)

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016)

Detection of alternative lengthening of telomeres by telomere quantitative PCR
por: Lau, Loretta M. S., et al.
Publicado: (2013)

ATRX represses alternative lengthening of telomeres
por: Napier, Christine E., et al.
Publicado: (2015)

Alternative Lengthening of Telomeres and Chromatin Status
por: Udroiu, Ion, et al.
Publicado: (2019)

Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma
por: Alessandrini, Irene, et al.
Publicado: (2022)

Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin
por: Episkopou, Harikleia, et al.
Publicado: (2014)

Telomeric replication stress: the beginning and the end for alternative lengthening of telomeres cancers
por: Lu, Robert, et al.
Publicado: (2022)

Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)
por: De Vitis, Marco, et al.
Publicado: (2018)

The Oncogenic Signaling Pathways in BRAF-Mutant Melanoma Cells Are Modulated by Naphthalene Diimide-Like G-Quadruplex Ligands
por: Recagni, Marta, et al.
Publicado: (2019)

G-quadruplexes mark alternative lengthening of telomeres
por: Yang, Sunny Y, et al.
Publicado: (2021)

Pan-Cancer Analysis of Alternative Lengthening of Telomere Activity
por: Sung, Ji-Yong, et al.
Publicado: (2020)

Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation
por: Ferreira, Monica Sofia Ventura, et al.
Publicado: (2020)

The roles of WRN and BLM RecQ helicases in the Alternative Lengthening of Telomeres
por: Mendez-Bermudez, Aaron, et al.
Publicado: (2012)

A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres
por: Mentegari, Elisa, et al.
Publicado: (2021)

Alternative Lengthening of Telomeres in the Budding Yeast Naumovozyma castellii
por: Cohn, Marita, et al.
Publicado: (2019)

Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: de Nonneville, Alexandre, et al.
Publicado: (2021)

Alternative Lengthening of Telomeres Is Rare in Canine Histiocytic Sarcoma
por: Kreilmeier-Berger, Theresa, et al.
Publicado: (2023)

Alternative lengthening of telomeres (ALT) in cancer stem cells in vivo
por: Bojovic, Bojana, et al.
Publicado: (2014)

Single-molecule analysis of subtelomeres and telomeres in Alternative Lengthening of Telomeres (ALT) cells
por: Abid, Heba Z., et al.
Publicado: (2020)

SETDB1-dependent heterochromatin stimulates alternative lengthening of telomeres
por: Gauchier, Mathilde, et al.
Publicado: (2019)

Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells
por: Zhao, Shuang, et al.
Publicado: (2019)

Oncogenic herpesvirus KSHV triggers hallmarks of alternative lengthening of telomeres
por: Lippert, Timothy P., et al.
Publicado: (2021)

Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
por: Hartlieb, Sabine A., et al.
Publicado: (2021)

Induction of the alternative lengthening of telomeres pathway by trapping of proteins on DNA
por: Rose, Anna M, et al.
Publicado: (2023)

Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs
por: Rosso, Ilaria, et al.
Publicado: (2023)

Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT)
por: Sun, Haolu, et al.
Publicado: (2023)

Alternative lengthening of telomeres is mechanistically linked to potential therapeutic vulnerability in the stem‐like subtype of gastric cancer
por: Sung, Ji‐Yong, et al.
Publicado: (2021)

Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
por: Maciejewska, Natalia, et al.
Publicado: (2022)

Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres
por: Muntoni, Alessandra, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dl3054pvjhail1rnlb1eg6a10t